Russia's Sputnik V vaccine shows 96.3% COVID-19 efficacy in Belarus - RDIF


Reuters | Moscow | Updated: 17-11-2021 13:26 IST | Created: 17-11-2021 13:17 IST
Russia's Sputnik V vaccine shows 96.3% COVID-19 efficacy in Belarus - RDIF
Representative image Image Credit: ANI
  • Country:
  • Russian Federation

Russia's Sputnik V vaccine has demonstrated 96.3% efficacy against COVID-19 during the vaccination campaign in Belarus, Russia's RDIF sovereign wealth fund said on Wednesday, down from 97.2% efficacy reported in September.

The Russian Direct Investment Fund, which is marketing the two-shot vaccine abroad, said the study was based on data from more than 1.2 million people who had been vaccinated with both Sputnik V components between January and September 2021.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)

Give Feedback